Jove
Visualize
Contact Us

Related Experiment Videos

Applying k-sample tests to conditional probabilities for competing risks in a clinical trial

M Lunn1

  • 1NHMRC Clinical Trials Centre, Sydney University, Australia. mlunn@stats.ox.ac.uk

Biometrics
|February 13, 1999
PubMed
Summary

This study introduces methods to analyze competing risks in cancer, focusing on disease progression. Estrogen receptor status impacts progression at current sites, while progesterone receptor status affects progression at new sites.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coupled virus - bacteria interactions and ecosystem function in an engineered microbial system.

Water research·2019
Same author

Agreement between amoA gene-specific quantitative PCR and fluorescence in situ hybridization in the measurement of ammonia-oxidizing bacteria in activated sludge.

Applied and environmental microbiology·2014
Same author

Unhappiness, health and cognitive ability in old age.

Psychological medicine·2007
Same author

An Australasian assessment of the basic treatment equivalent model derived from New South Wales data.

Australasian radiology·2000
Same author

Refinement of the basic treatment equivalent model to reflect radiotherapy treatment throughput using Australasian data.

Australasian radiology·2000
Same author

Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Biostatistics
  • Clinical Oncology

Background:

  • Analyzing competing risks is crucial for a comprehensive understanding of patient outcomes.
  • Cumulative incidence functions and conditional probabilities offer insights into specific risk events.

Purpose of the Study:

  • To develop statistical methods for comparing samples in the presence of competing risks.
  • To investigate prognostic factors for disease progression in advanced breast cancer patients.

Main Methods:

  • Utilized cumulative incidence functions to model competing risks.
  • Derived kappa-sample tests of significance and stratified test statistics.
  • Applied methods to a clinical trial dataset of advanced breast cancer patients.

Main Results:

Related Experiment Videos

  • Estrogen receptor status (ER+) is a significant prognostic factor for time to progression at current tumor sites.
  • Progesterone receptor status (PR+) is significant for disease progression at new sites.
  • Stratified analysis adjusted for disease spread, confirming ER+ importance.

Conclusions:

  • The developed statistical methods effectively analyze competing risks in clinical data.
  • ER+ status is a key predictor for progression at existing sites, while PR+ status is relevant for new site progression in advanced breast cancer.